arrow
Back
F

Federico Rojo

pathology department

71H-index
781Paper Count
2.3WCitation Count
Published Papers 182
Publication Date
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2− Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy
err2026-06-17
err0
errOAAI
errFederico Rojo; Valentina Guarneri; Nicola Fusco; Stefano Indraccolo; Isabelle Vanden Bempt; Elena Guerini Rocco; Ruth Sardinha; Isaac García-Murillas; Riccardo Adorisio; Andrea Boscolo Bragadin; Nerea Carvajal; Francesco Pepe; Sandra Pérez-Buira; Ivan Prieto-Potin; Demi Renders; Gianluca Russo; Claudia Scimone; Claire Swift; Konstantinos Venetis; Sandra Zazo; Umberto Malapelle
errShare
errSave
Brief report: Artificial intelligence meets small cell lung cancer—integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC
err2026-04-20
err0
errOAAI
errPR Pedro Rocha †; JG Joan Gibert †; SM Silvía Menendez; RD Raúl del Rey-Vergara; AI Albert Iñañez; LM Laura Masfarré; NN Nil Navarro; AR Alejandro Ríos-Hoyo; SP Sandra Perez; ÁT Álvaro Taus; MG Mario Giner; AR Ana Rovira; LL Luis León-Mateos; DI Dolores Isla; LP Luis Paz-Ares; JZ Jon Zugazagoitia; CM Cristina Martí Blanco; RG Rosario García-Campelo; AM Alberto Moreno-Vega; ÁC Ángel Callejo; FR Federico Rojo; IS Ignacio Sanchéz; EA Edurne Arriola
errShare
errSave
CLDN18.2 expression in gastroesophageal adenocarcinoma: prevalence, heterogeneity, and prognostic implications in Spanish patients
err2025-11-09
err0
errOAAI
errCarolina Martinez-Ciarpaglini; María Ortega; Sandra Pérez-Buira; Aitana Bolea; Beatriz Casado Guerra; Carmen Herencia Bellido; Paula Tornero Piñero; Dolores Naranjo-Hans; Brenda Palomar; Hernán Quiceno; Amanda Sardón Fernández; Ariadna Torner Calvo; Federico Rojo; Mar Iglesias Coma
errShare
errSave
PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significance
err2025-08-11
err0
PREAI
errLuis Fernando García; Esther Conde; Susana Hernandez; Marta Alonso; Daniel Curto; Manuel Dómine; Federico Rojo; Javier Freire; Javier Gómez-Román; Antonio Calles; María Cebollero; José Luis González-Larriba; Melchor Saiz; Isabel Esteban; Laura Gutiérrez; Fernando Lopez-Rios; Javier de Castro
errShare
errSave
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
err2025-07-10
err0
errOAAI
errCatalina Rozalén; Irene Sangrador; Silvia Avalle; Sandra Blasco-Benito; Panagiota Tzortzi; María Sanz-Flores; José Ángel Palomeque; Pau Torren-Duran; Mariona Dalmau; Helena Brunel; Albert Coll-Manzano; Iván Pérez-Núñez; Tamara Martos; Sonia Servitja; Sandra Pérez-Buira; José Ignacio Chacón; Ángel Guerrero-Zotano; Eduardo Martínez de Dueñas; Yolanda Guillén; Laura Comerma; Begoña Bermejo; Anna Bigas; María Casanova-Acebes; Anna Alemany; Federico Rojo; Joan Albanell; Toni Celià-Terrassa
errShare
errSave
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial
err2025-06-20
err0
errOAAI
errJoan Albanell; Angelo Gámez Pozo; Carlos L. Arteaga; Meritxell Bellet; Federico Rojo; Abel González; Beatriz Bellosillo; Violeta Serra; Petra Gener; José Antonio Guerrero; Eileen Shimizu; Mario Mancino; Jose Rodríguez-Morató; Leonardo Mina; José Manuel Pérez-García; Javier Cortés; Antonio Llombart-Cussac
errShare
errSave
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer
err2025-06-20
err0
errOAAI
errRaúl del Rey-Vergara; Miguel Alejandro Galindo-Campos; Pedro Rocha; Marina Carpes; Carlos Martínez; Laura Masfarré; Silvia Menéndez; Fabricio Quimis; Adrià Rossell; Albert Iñañez; Sandra Pérez-Buira; Federico Rojo; Ramon Gimeno; Dolores Isla; Jon Zugazagoitia; Cristina Martí Blanco; Rosario García-Campelo; Alberto Moreno-Vega; Luis León-Mateos; Ángel Callejo Mellén; Kwon-Sik Park; Simon Heeke; John V. Heymach; Álvaro Taus; Luis Paz-Ares; Ana Rovira; Edurne Arriola
errShare
errSave
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer
err2025-03-25
err0
errOAAI
errLameirinhas, Ana; Torres-Ruiz, Sandra; Garrido-Cano, Iris; Hernando, Cristina; Martinez, Maria Teresa; Rovira, Ana; Albanell, Joan; Zazo, Sandra; Rojo, Federico; Bermejo, Begona; Lluch, Ana; Cejalvo, Juan Miguel; Tormo, Eduardo; Eroles, Pilar
errShare
errSave
Implementing digital pathology: qualitative and financial insights from eight leading European laboratories
err2025-03-01
err0
errOAAI
errMatias-Guiu, Xavier; Temprana-Salvador, Jordi; Lopez, Pablo Garcia; Kammerer-Jacquet, Solene-Florence; Rioux-Leclercq, Nathalie; Clark, David; Schuerch, Christian M.; Fend, Falko; Mattern, Sven; Snead, David; Fusco, Nicola; Guerini-Rocco, Elena; Rojo, Federico; Brevet, Marie; Tellez, Manuel Salto; Dei Tos, Angelo; di Maio, Thomas; Ramirez-Peinado, Silvia; Sheppard, Elizabeth; Bannister, Huw; Gkiokas, Anastasios; Arpaia, Mario; Ben Dhia, Ons; Martino, Nazario
errShare
errSave
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer
err2025-02-12
err0
errOAAI
errMadoz-Gurpide, Juan; Serrano-Lopez, Juana; Sanz-alvarez, Marta; Morales-Gallego, Miriam; Rodriguez-Pinilla, Socorro Maria; Rovira, Ana; Albanell, Joan; Rojo, Federico
errShare
errSave
The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer
err2025-02-03
err0
errOAAI
errInanez, Albert; del Rey-Vergara, Raul; Quimis, Fabricio; Rocha, Pedro; Galindo, Miguel; Menendez, Silvia; Masfarre, Laura; Sanchez, Ignacio; Carpes, Marina; Martinez, Carlos; Perez-Buira, Sandra; Rojo, Federico; Rovira, Ana; Arriola, Edurne
errShare
errSave
Gestational breast cancer: distinctive molecular and clinico-epidemiological features
err2024-11-08
err1
errOAAI
errde la Haba-Rodriguez, J. R.; Minguez, P.; Rojo, F.; Martin, M.; Alba, E.; Servitja, S.; Prat, A.; Perez-Fidalgo, J. A.; Gavila, J.; Morales, C.; Rodriguez-Lescure, A.; Herrero, C.; Pena-Enriquez, R.; Herranz, J.; Hernando, C.; Hernandez-Blanquisett, A.; Guil-Luna, S.; Martinez, M. T.; Blanch, S.; Caballero, R.; Martin, N.; Pollan, M.; Guerrero-Zotano, A.; Bermejo, B.
errShare
errSave
Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors
err2024-09-11
err1
errOAAI
errHernandez-Prat, Anna; Rodriguez-Vida, Alejo; Cardona, Laura; Qin, Mengjuan; Arpi-Llucia, Oriol; Soria-Jimenez, Luis; Menendez, Silvia; Quimis, Fabricio Gerel; Galindo, Miguel; Arriola, Edurne; Salido, Marta; Juanpere-Rodero, Nuria; Rojo, Federico; Muntasell, Aura; Albanell, Joan; Rovira, Ana; Bellmunt, Joaquim
errShare
errSave
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
err2024-08-22
err2
errOAAI
errTorres-Ruiz, Sandra; Garrido-Cano, Iris; Lameirinhas, Ana; Burgues, Octavio; Hernando, Cristina; Martinez, Maria Teresa; Rojo, Federico; Bermejo, Begona; Tapia, Marta; Carbonell-Asins, Juan Antonio; Pena, Carlos Javier; Lluch, Ana; Cejalvo, Juan Miguel; Tormo, Eduardo; Eroles, Pilar
errShare
errSave
Randomized Phase II trial evaluating three antidiarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
err2024-05-02
err0
PREAI
errGil-Gil, Miguel; Martin, Miguel; Carrasco, Eva; Galve, Elena; Martinez-Janez, Noelia; Gonzalez-Santiago, Santiago; Adamo, Barbara; Valero, Maria; Martinez, Clara; Guerrero, Angel; Novoa, Silvia Antolin; Ruiz-Borrego, Manuel; Blancas, Isabel; Andres, Raquel; Alonso-Romero, Jose L.; Andrea, Vethencourt; Chacon, J. Ignacio; Chavarria, Natalia; Espinosa, Enrique; Hernando, Blanca; Adrover, Encarnacion; Rojo, Federico; Casas, Maribel; McCulloch, Leanne; Vedovato, Jean-Claude
errShare
errSave
Real-world features and outcomes of young advanced breast cancer (ABC) patients (pts) from RegistEM (GEICAM/2014-03) study
err2024-05-02
err0
PREAI
errLopez-Tarruella, Sara; Guerrero, Angel; Alvarez, Isabel; Novoa, Silvia Antolin; Tibau, Ariadna; Cruz, Josefina; Rodriguez, Cesar A.; Martinez, Purificacion; Chacon, J. Ignacio; Hernandez, Maria; Margeli, Mireia; Adrover, Encarna; Falo, Catalina; Gonzalez, Iria; Rodriguez-Lescure, Alvaro; Marin, Maria; Gomez, Cesar; de la Haba-Rodriguez, Juan; Illaramendi, J. Jose; Andres, Raquel; Blasco, Andrea; Escudero, Ma Jose; Bezares, Susana; Rojo, Federico
errShare
errSave
Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments
err2024-04-04
err1
PREAI
errRueschoff, Josef; Kumar, George; Badve, Sunil; Jasani, Bharat; Krause, Emma; Rioux-Leclercq, Nathalie; Rojo, Federico; Martini, Maurizio; Cheng, Liang; Tretiakova, Maria; Mitchell, Catherine; Anders, Robert A.; Robert, Marie E.; Fahy, Darren; Pyle, Mike; Le, Quang; Yu, Limin; Glass, Benjamin; Baxi, Vipul; Babadjanova, Zulfia; Pratt, James; Brutus, Sergine; Karasarides, Maria; Hartmann, Arndt
errShare
errSave
RET Fusion Testing in Patients With NSCLC: The RETING Study
err2024-04-01
err2
errOAAI
errConde, Esther; Hernandez, Susana; Carrillo, Jose Luis Rodriguez; Martinez, Rebeca; Alonso, Marta; Curto, Daniel; Jimenez, Beatriz; Caminoa, Alejandra; Benito, Amparo; Garrido, Pilar; Clave, Sergi; Arriola, Edurne; Esteban-Rodriguez, Isabel; De Castro, Javier; Sansano, Irene; Felip, Enriqueta; Rojo, Federico; Domine, Manuel; Abdulkader, Ihab; Garcia-Gonzalez, Jorge; Teixido, Cristina; Reguart, Noemi; Compan, Desamparados; Insa, Amelia; Mancheno, Nuria; Palanca, Sarai; Juan-Vidal, Oscar; Baixeras, Nuria; Nadal, Ernest; Cebollero, Maria; Calles, Antonio; Martin, Paloma; Salas, Clara; Provencio, Mariano; Aranda, Ignacio; Massuti, Bartomeu; Lopez-Vilaro, Laura; Majem, Margarita; Paz-Ares, Luis; Lopez-Rios, Fernando
errShare
errSave
Prospective evaluation of predictive biomarkers for Palbociclib (P) and endocrine therapy (ET) benefit in hormone receptor (HR)-positive [ plus ]/human epidermal growth factor receptor 2 (HER2)-negative [-] advanced breast cancer (ABC) patients (pts) from PARSIFAL clinical trial: The transFAL sub-study
err2024-03-22
err0
PREAI
errAlbanell, Joan; Pozo, Angelo Gamez; Arteaga, Carlos L.; Bellet, Meritxell; Rojo, Federico; Gonzalez, Abel; Bellosillo, Beatriz; Serra, Violeta; Gener, Petra; Guerrero, Jose Antonio; Lopez-Montero, Laura; Mancino, Mario; Rodriguez-Morato, Jose; Mina, Leonardo; Perez-Garcia, Jose Manuel; Cortes, Javier; Llombart-Cussac, Antonio
errShare
errSave
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer
err2024-01-03
err5
errOAAI
errSantana-Hernandez, Sara; Suarez-Olmos, Jesus; Servitja, Sonia; Berenguer-Molins, Pau; Costa-Garcia, Marcel; Comerma, Laura; Rea, Anna; Perera-Bel, Julia; Menendez, Silvia; Arpi, Oriol; Bermejo, Begona; Martinez, Maria Teresa; Cejalvo, Juan Miguel; Comino-Mendez, Inaki; Pascual, Javier; Alba, Emilio; Lopez-Botet, Miguel; Rojo, Federico; Rovira, Ana; Albanell, Joan; Muntasell, Aura
errShare
errSave